Listed

Twist Bioscience Corp

TWSTNasdaqCIK 1581280HealthcareFiscal year ends Sep 30

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$118.4m, Q3 FY2026
Operating income−$36.3m, Q3 FY2026
Net income−$35.1m, Q3 FY2026
Twist Bioscience Corp, income statement, quarterly
Line itemUnitQ4 FY20232023-09-30Q1 FY20242023-12-31Q2 FY20242024-03-31Q3 FY20242024-06-30Q4 FY20242024-09-30Q1 FY20252024-12-31Q2 FY20252025-03-31Q3 FY20252025-06-30Q4 FY20252025-09-30Q1 FY20262025-12-31Q2 FY20262026-03-31Q3 FY20262026-06-30
Revenue$m66.9Revenue, Q4 FY2023, three months to 2023-09-30$66.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-K filed 2025-11-17, accession 0001581280-25-000025. Derived: 12-month figure less the 9-month figure.Report this figure71.5Revenue, Q1 FY2024, three months to 2023-12-31$71.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2025-02-03, accession 0001628280-25-003461.Report this figure75.3Revenue, Q2 FY2024, three months to 2024-03-31$75.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2025-05-05, accession 0001628280-25-022154.Report this figure81.5Revenue, Q3 FY2024, three months to 2024-06-30$81.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2025-08-04, accession 0001581280-25-000009.Report this figure84.7Revenue, Q4 FY2024, three months to 2024-09-30$84.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-K filed 2025-11-17, accession 0001581280-25-000025. Derived: 12-month figure less the 9-month figure.Report this figure88.7Revenue, Q1 FY2025, three months to 2024-12-31$88.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q/A filed 2026-02-26, accession 0001581280-26-000029.Report this figure92.8Revenue, Q2 FY2025, three months to 2025-03-31$92.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2026-05-04, accession 0001581280-26-000040.Report this figure96.1Revenue, Q3 FY2025, three months to 2025-06-30$96.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2026-08-03, accession 0001581280-26-000047.Report this figure99.0Revenue, Q4 FY2025, three months to 2025-09-30$99.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-K filed 2025-11-17, accession 0001581280-25-000025. Derived: 12-month figure less the 9-month figure.Report this figure104Revenue, Q1 FY2026, three months to 2025-12-31$103.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q/A filed 2026-02-26, accession 0001581280-26-000029.Report this figure111Revenue, Q2 FY2026, three months to 2026-03-31$110.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2026-05-04, accession 0001581280-26-000040.Report this figure118Revenue, Q3 FY2026, three months to 2026-06-30$118.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2026-08-03, accession 0001581280-26-000047.Report this figure
Cost of revenue$m42.4Cost of revenue, Q4 FY2023, three months to 2023-09-30$42.4m. XBRL concept us-gaap:CostOfRevenue. 10-K filed 2025-11-17, accession 0001581280-25-000025. Derived: 12-month figure less the 9-month figure.Report this figure42.5Cost of revenue, Q1 FY2024, three months to 2023-12-31$42.5m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2025-02-03, accession 0001628280-25-003461.Report this figure44.4Cost of revenue, Q2 FY2024, three months to 2024-03-31$44.4m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2025-05-05, accession 0001628280-25-022154.Report this figure46.2Cost of revenue, Q3 FY2024, three months to 2024-06-30$46.2m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2025-08-04, accession 0001581280-25-000009.Report this figure46.5Cost of revenue, Q4 FY2024, three months to 2024-09-30$46.5m. XBRL concept us-gaap:CostOfRevenue. 10-K filed 2025-11-17, accession 0001581280-25-000025. Derived: 12-month figure less the 9-month figure.Report this figure45.9Cost of revenue, Q1 FY2025, three months to 2024-12-31$45.9m. XBRL concept us-gaap:CostOfRevenue. 10-Q/A filed 2026-02-26, accession 0001581280-26-000029.Report this figure46.8Cost of revenue, Q2 FY2025, three months to 2025-03-31$46.8m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-05-04, accession 0001581280-26-000040.Report this figure44.8Cost of revenue, Q3 FY2025, three months to 2025-06-30$44.8m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-08-03, accession 0001581280-26-000047.Report this figure48.2Cost of revenue, Q4 FY2025, three months to 2025-09-30$48.2m. XBRL concept us-gaap:CostOfRevenue. 10-K filed 2025-11-17, accession 0001581280-25-000025. Derived: 12-month figure less the 9-month figure.Report this figure49.7Cost of revenue, Q1 FY2026, three months to 2025-12-31$49.7m. XBRL concept us-gaap:CostOfRevenue. 10-Q/A filed 2026-02-26, accession 0001581280-26-000029.Report this figure53.6Cost of revenue, Q2 FY2026, three months to 2026-03-31$53.6m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-05-04, accession 0001581280-26-000040.Report this figure55.9Cost of revenue, Q3 FY2026, three months to 2026-06-30$55.9m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-08-03, accession 0001581280-26-000047.Report this figure
Research and development$m23.7Research and development, Q4 FY2023, three months to 2023-09-30$23.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-11-17, accession 0001581280-25-000025. Derived: 12-month figure less the 9-month figure.Report this figure23.1Research and development, Q1 FY2024, three months to 2023-12-31$23.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-02-03, accession 0001628280-25-003461.Report this figure24.1Research and development, Q2 FY2024, three months to 2024-03-31$24.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-05, accession 0001628280-25-022154.Report this figure22.5Research and development, Q3 FY2024, three months to 2024-06-30$22.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-04, accession 0001581280-25-000009.Report this figure21.1Research and development, Q4 FY2024, three months to 2024-09-30$21.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-11-17, accession 0001581280-25-000025. Derived: 12-month figure less the 9-month figure.Report this figure21.3Research and development, Q1 FY2025, three months to 2024-12-31$21.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q/A filed 2026-02-26, accession 0001581280-26-000029.Report this figure23.9Research and development, Q2 FY2025, three months to 2025-03-31$23.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-04, accession 0001581280-26-000040.Report this figure18.0Research and development, Q3 FY2025, three months to 2025-06-30$18.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-03, accession 0001581280-26-000047.Report this figure17.0Research and development, Q4 FY2025, three months to 2025-09-30$17.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-11-17, accession 0001581280-25-000025. Derived: 12-month figure less the 9-month figure.Report this figure17.1Research and development, Q1 FY2026, three months to 2025-12-31$17.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q/A filed 2026-02-26, accession 0001581280-26-000029.Report this figure19.7Research and development, Q2 FY2026, three months to 2026-03-31$19.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-04, accession 0001581280-26-000040.Report this figure18.0Research and development, Q3 FY2026, three months to 2026-06-30$18.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-03, accession 0001581280-26-000047.Report this figure
Selling, general and administrative$m47.4Selling, general and administrative, Q4 FY2023, three months to 2023-09-30$47.4m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2025-11-17, accession 0001581280-25-000025. Derived: 12-month figure less the 9-month figure.Report this figure52.8Selling, general and administrative, Q1 FY2024, three months to 2023-12-31$52.8m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-02-03, accession 0001628280-25-003461.Report this figure55.6Selling, general and administrative, Q2 FY2024, three months to 2024-03-31$55.6m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-05-05, accession 0001628280-25-022154.Report this figure56.8Selling, general and administrative, Q3 FY2024, three months to 2024-06-30$56.8m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-08-04, accession 0001581280-25-000009.Report this figure53.1Selling, general and administrative, Q4 FY2024, three months to 2024-09-30$53.1m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2025-11-17, accession 0001581280-25-000025. Derived: 12-month figure less the 9-month figure.Report this figure56.2Selling, general and administrative, Q1 FY2025, three months to 2024-12-31$56.2m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q/A filed 2026-02-26, accession 0001581280-26-000029.Report this figure63.7Selling, general and administrative, Q2 FY2025, three months to 2025-03-31$63.7m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-04, accession 0001581280-26-000040.Report this figure63.4Selling, general and administrative, Q3 FY2025, three months to 2025-06-30$63.4m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-03, accession 0001581280-26-000047.Report this figure63.8Selling, general and administrative, Q4 FY2025, three months to 2025-09-30$63.8m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2025-11-17, accession 0001581280-25-000025. Derived: 12-month figure less the 9-month figure.Report this figure69.7Selling, general and administrative, Q1 FY2026, three months to 2025-12-31$69.7m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q/A filed 2026-02-26, accession 0001581280-26-000029.Report this figure76.1Selling, general and administrative, Q2 FY2026, three months to 2026-03-31$76.1m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-04, accession 0001581280-26-000040.Report this figure80.7Selling, general and administrative, Q3 FY2026, three months to 2026-06-30$80.7m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-03, accession 0001581280-26-000047.Report this figure
Operating income$m(50.1)Operating income, Q4 FY2023, three months to 2023-09-30−$50.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-11-17, accession 0001581280-25-000025. Derived: 12-month figure less the 9-month figure.Report this figure(47.0)Operating income, Q1 FY2024, three months to 2023-12-31−$47.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-02-03, accession 0001628280-25-003461.Report this figure(48.9)Operating income, Q2 FY2024, three months to 2024-03-31−$48.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-05, accession 0001628280-25-022154.Report this figure(88.9)Operating income, Q3 FY2024, three months to 2024-06-30−$88.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-04, accession 0001581280-25-000009.Report this figure(36.0)Operating income, Q4 FY2024, three months to 2024-09-30−$36.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-11-17, accession 0001581280-25-000025. Derived: 12-month figure less the 9-month figure.Report this figure(34.6)Operating income, Q1 FY2025, three months to 2024-12-31−$34.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q/A filed 2026-02-26, accession 0001581280-26-000029.Report this figure(41.6)Operating income, Q2 FY2025, three months to 2025-03-31−$41.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-04, accession 0001581280-26-000040.Report this figure(30.1)Operating income, Q3 FY2025, three months to 2025-06-30−$30.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-03, accession 0001581280-26-000047.Report this figure(29.9)Operating income, Q4 FY2025, three months to 2025-09-30−$29.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-11-17, accession 0001581280-25-000025. Derived: 12-month figure less the 9-month figure.Report this figure(32.9)Operating income, Q1 FY2026, three months to 2025-12-31−$32.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q/A filed 2026-02-26, accession 0001581280-26-000029.Report this figure(45.9)Operating income, Q2 FY2026, three months to 2026-03-31−$45.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-04, accession 0001581280-26-000040.Report this figure(36.3)Operating income, Q3 FY2026, three months to 2026-06-30−$36.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-03, accession 0001581280-26-000047.Report this figure
Interest expense$m0.0Interest expense, Q4 FY2023, three months to 2023-09-30$1.0k. XBRL concept us-gaap:InterestExpense. 10-K filed 2023-11-21, accession 0001628280-23-039767. Derived: 12-month figure less the 9-month figure.Report this figure0.0Interest expense, Q1 FY2024, three months to 2023-12-31$0. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-02-02, accession 0001628280-24-003051.Report this figure0.0Interest expense, Q2 FY2024, three months to 2024-03-31$0. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-05-02, accession 0001628280-24-020014.Report this figure0.0Interest expense, Q3 FY2024, three months to 2024-06-30$0. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2024-08-02, accession 0001628280-24-034434.Report this figure0.0Interest expense, Q4 FY2024, three months to 2024-09-30$29.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2024-11-18, accession 0001628280-24-048262. Derived: 12-month figure less the 9-month figure.Report this figure0.0Interest expense, Q1 FY2025, three months to 2024-12-31$24.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-02-03, accession 0001628280-25-003461.Report this figure0.1Interest expense, Q2 FY2025, three months to 2025-03-31$143.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-05-05, accession 0001628280-25-022154.Report this figurenot reportednot reportednot reportednot reportednot reported
Income tax$m(0.2)Income tax, Q4 FY2023, three months to 2023-09-30−$222.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2025-11-17, accession 0001581280-25-000025. Derived: 12-month figure less the 9-month figure.Report this figure0.1Income tax, Q1 FY2024, three months to 2023-12-31$120.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-02-03, accession 0001628280-25-003461.Report this figure0.3Income tax, Q2 FY2024, three months to 2024-03-31$345.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-05-05, accession 0001628280-25-022154.Report this figure0.2Income tax, Q3 FY2024, three months to 2024-06-30$191.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-08-04, accession 0001581280-25-000009.Report this figure(0.1)Income tax, Q4 FY2024, three months to 2024-09-30−$96.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2025-11-17, accession 0001581280-25-000025. Derived: 12-month figure less the 9-month figure.Report this figure0.1Income tax, Q1 FY2025, three months to 2024-12-31$97.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q/A filed 2026-02-26, accession 0001581280-26-000029.Report this figure0.2Income tax, Q2 FY2025, three months to 2025-03-31$175.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-04, accession 0001581280-26-000040.Report this figure0.2Income tax, Q3 FY2025, three months to 2025-06-30$191.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-03, accession 0001581280-26-000047.Report this figure0.3Income tax, Q4 FY2025, three months to 2025-09-30$257.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2025-11-17, accession 0001581280-25-000025. Derived: 12-month figure less the 9-month figure.Report this figure0.3Income tax, Q1 FY2026, three months to 2025-12-31$253.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q/A filed 2026-02-26, accession 0001581280-26-000029.Report this figure0.0Income tax, Q2 FY2026, three months to 2026-03-31$43.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-04, accession 0001581280-26-000040.Report this figure0.3Income tax, Q3 FY2026, three months to 2026-06-30$311.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-03, accession 0001581280-26-000047.Report this figure
Net income$m(46.2)Net income, Q4 FY2023, three months to 2023-09-30−$46.2m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-11-17, accession 0001581280-25-000025. Derived: 12-month figure less the 9-month figure.Report this figure(43.0)Net income, Q1 FY2024, three months to 2023-12-31−$43.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-02-03, accession 0001628280-25-003461.Report this figure(45.5)Net income, Q2 FY2024, three months to 2024-03-31−$45.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-05-05, accession 0001628280-25-022154.Report this figure(85.6)Net income, Q3 FY2024, three months to 2024-06-30−$85.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-08-04, accession 0001581280-25-000009.Report this figure(34.7)Net income, Q4 FY2024, three months to 2024-09-30−$34.7m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-11-17, accession 0001581280-25-000025. Derived: 12-month figure less the 9-month figure.Report this figure(31.6)Net income, Q1 FY2025, three months to 2024-12-31−$31.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q/A filed 2026-02-26, accession 0001581280-26-000029.Report this figure(39.3)Net income, Q2 FY2025, three months to 2025-03-31−$39.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-04, accession 0001581280-26-000040.Report this figure20.4Net income, Q3 FY2025, three months to 2025-06-30$20.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-03, accession 0001581280-26-000047.Report this figure(27.1)Net income, Q4 FY2025, three months to 2025-09-30−$27.1m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-11-17, accession 0001581280-25-000025. Derived: 12-month figure less the 9-month figure.Report this figure(30.5)Net income, Q1 FY2026, three months to 2025-12-31−$30.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q/A filed 2026-02-26, accession 0001581280-26-000029.Report this figure(44.0)Net income, Q2 FY2026, three months to 2026-03-31−$44.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-04, accession 0001581280-26-000040.Report this figure(35.1)Net income, Q3 FY2026, three months to 2026-06-30−$35.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-03, accession 0001581280-26-000047.Report this figure
Diluted EPS$ per sharenot reported(0.75)Diluted EPS, Q1 FY2024, three months to 2023-12-31−$0.75 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-02-03, accession 0001628280-25-003461.Report this figure(0.79)Diluted EPS, Q2 FY2024, three months to 2024-03-31−$0.79 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-05, accession 0001628280-25-022154.Report this figure(1.47)Diluted EPS, Q3 FY2024, three months to 2024-06-30−$1.47 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-04, accession 0001581280-25-000009.Report this figurenot reported(0.53)Diluted EPS, Q1 FY2025, three months to 2024-12-31−$0.53 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q/A filed 2026-02-26, accession 0001581280-26-000029.Report this figure(0.66)Diluted EPS, Q2 FY2025, three months to 2025-03-31−$0.66 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-04, accession 0001581280-26-000040.Report this figure0.33Diluted EPS, Q3 FY2025, three months to 2025-06-30$0.33 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-03, accession 0001581280-26-000047.Report this figurenot reported(0.50)Diluted EPS, Q1 FY2026, three months to 2025-12-31−$0.50 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q/A filed 2026-02-26, accession 0001581280-26-000029.Report this figure(0.71)Diluted EPS, Q2 FY2026, three months to 2026-03-31−$0.71 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-04, accession 0001581280-26-000040.Report this figure(0.56)Diluted EPS, Q3 FY2026, three months to 2026-06-30−$0.56 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-03, accession 0001581280-26-000047.Report this figure
Basic EPS$ per sharenot reported(0.75)Basic EPS, Q1 FY2024, three months to 2023-12-31−$0.75 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-02-03, accession 0001628280-25-003461.Report this figure(0.79)Basic EPS, Q2 FY2024, three months to 2024-03-31−$0.79 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-05, accession 0001628280-25-022154.Report this figure(1.47)Basic EPS, Q3 FY2024, three months to 2024-06-30−$1.47 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-04, accession 0001581280-25-000009.Report this figurenot reported(0.53)Basic EPS, Q1 FY2025, three months to 2024-12-31−$0.53 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q/A filed 2026-02-26, accession 0001581280-26-000029.Report this figure(0.66)Basic EPS, Q2 FY2025, three months to 2025-03-31−$0.66 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-04, accession 0001581280-26-000040.Report this figure0.34Basic EPS, Q3 FY2025, three months to 2025-06-30$0.34 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-03, accession 0001581280-26-000047.Report this figurenot reported(0.50)Basic EPS, Q1 FY2026, three months to 2025-12-31−$0.50 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q/A filed 2026-02-26, accession 0001581280-26-000029.Report this figure(0.71)Basic EPS, Q2 FY2026, three months to 2026-03-31−$0.71 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-04, accession 0001581280-26-000040.Report this figure(0.56)Basic EPS, Q3 FY2026, three months to 2026-06-30−$0.56 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-03, accession 0001581280-26-000047.Report this figure

Balance sheet

Cash and equivalents$117.4m, Q3 FY2026
Shareholders' equity$445.7m, Q3 FY2026
Twist Bioscience Corp, balance sheet, quarterly
Line itemUnitFY20232023-09-30Q1 FY20242023-12-31Q2 FY20242024-03-31Q3 FY20242024-06-30FY20242024-09-30Q1 FY20252024-12-31Q2 FY20252025-03-31Q3 FY20252025-06-30FY20252025-09-30Q1 FY20262025-12-31Q2 FY20262026-03-31Q3 FY20262026-06-30
Cash and equivalents$m286Cash and equivalents, FY2023, at 2023-09-30$286.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2024-11-18, accession 0001628280-24-048262.Report this figure266Cash and equivalents, Q1 FY2024, at 2023-12-31$266.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-02-02, accession 0001628280-24-003051.Report this figure243Cash and equivalents, Q2 FY2024, at 2024-03-31$243.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-05-02, accession 0001628280-24-020014.Report this figure239Cash and equivalents, Q3 FY2024, at 2024-06-30$239.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-08-02, accession 0001628280-24-034434.Report this figure226Cash and equivalents, FY2024, at 2024-09-30$226.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-11-17, accession 0001581280-25-000025.Report this figure221Cash and equivalents, Q1 FY2025, at 2024-12-31$221.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-02-03, accession 0001628280-25-003461.Report this figure210Cash and equivalents, Q2 FY2025, at 2025-03-31$210.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-05, accession 0001628280-25-022154.Report this figure201Cash and equivalents, Q3 FY2025, at 2025-06-30$201.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-04, accession 0001581280-25-000009.Report this figure183Cash and equivalents, FY2025, at 2025-09-30$183.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-03, accession 0001581280-26-000047.Report this figure149Cash and equivalents, Q1 FY2026, at 2025-12-31$148.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q/A filed 2026-02-26, accession 0001581280-26-000029.Report this figure123Cash and equivalents, Q2 FY2026, at 2026-03-31$122.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-04, accession 0001581280-26-000040.Report this figure117Cash and equivalents, Q3 FY2026, at 2026-06-30$117.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-03, accession 0001581280-26-000047.Report this figure
Current assets$m424Current assets, FY2023, at 2023-09-30$424.3m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2024-11-18, accession 0001628280-24-048262.Report this figure390Current assets, Q1 FY2024, at 2023-12-31$390.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-02-02, accession 0001628280-24-003051.Report this figure372Current assets, Q2 FY2024, at 2024-03-31$371.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-02, accession 0001628280-24-020014.Report this figure362Current assets, Q3 FY2024, at 2024-06-30$361.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-02, accession 0001628280-24-034434.Report this figure347Current assets, FY2024, at 2024-09-30$346.8m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-11-17, accession 0001581280-25-000025.Report this figure345Current assets, Q1 FY2025, at 2024-12-31$345.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-02-03, accession 0001628280-25-003461.Report this figure338Current assets, Q2 FY2025, at 2025-03-31$338.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-05, accession 0001628280-25-022154.Report this figure340Current assets, Q3 FY2025, at 2025-06-30$339.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-04, accession 0001581280-25-000009.Report this figure333Current assets, FY2025, at 2025-09-30$333.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-03, accession 0001581280-26-000047.Report this figure304Current assets, Q1 FY2026, at 2025-12-31$303.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q/A filed 2026-02-26, accession 0001581280-26-000029.Report this figure323Current assets, Q2 FY2026, at 2026-03-31$323.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-04, accession 0001581280-26-000040.Report this figure321Current assets, Q3 FY2026, at 2026-06-30$321.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-03, accession 0001581280-26-000047.Report this figure
Total assets$m776Total assets, FY2023, at 2023-09-30$776.4m. XBRL concept us-gaap:Assets. 10-K filed 2024-11-18, accession 0001628280-24-048262.Report this figure733Total assets, Q1 FY2024, at 2023-12-31$732.8m. XBRL concept us-gaap:Assets. 10-Q filed 2024-02-02, accession 0001628280-24-003051.Report this figure703Total assets, Q2 FY2024, at 2024-03-31$702.8m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-02, accession 0001628280-24-020014.Report this figure638Total assets, Q3 FY2024, at 2024-06-30$638.1m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-02, accession 0001628280-24-034434.Report this figure614Total assets, FY2024, at 2024-09-30$614.3m. XBRL concept us-gaap:Assets. 10-K filed 2025-11-17, accession 0001581280-25-000025.Report this figure609Total assets, Q1 FY2025, at 2024-12-31$608.6m. XBRL concept us-gaap:Assets. 10-Q filed 2025-02-03, accession 0001628280-25-003461.Report this figure596Total assets, Q2 FY2025, at 2025-03-31$595.6m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-05, accession 0001628280-25-022154.Report this figure644Total assets, Q3 FY2025, at 2025-06-30$643.6m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-04, accession 0001581280-25-000009.Report this figure642Total assets, FY2025, at 2025-09-30$641.9m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-03, accession 0001581280-26-000047.Report this figure638Total assets, Q1 FY2026, at 2025-12-31$638.1m. XBRL concept us-gaap:Assets. 10-Q/A filed 2026-02-26, accession 0001581280-26-000029.Report this figure676Total assets, Q2 FY2026, at 2026-03-31$676.2m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-04, accession 0001581280-26-000040.Report this figure672Total assets, Q3 FY2026, at 2026-06-30$672.4m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-03, accession 0001581280-26-000047.Report this figure
Current liabilities$m73.3Current liabilities, FY2023, at 2023-09-30$73.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2024-11-18, accession 0001628280-24-048262.Report this figure65.2Current liabilities, Q1 FY2024, at 2023-12-31$65.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-02-02, accession 0001628280-24-003051.Report this figure67.5Current liabilities, Q2 FY2024, at 2024-03-31$67.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-02, accession 0001628280-24-020014.Report this figure73.8Current liabilities, Q3 FY2024, at 2024-06-30$73.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-02, accession 0001628280-24-034434.Report this figure71.0Current liabilities, FY2024, at 2024-09-30$71.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-11-17, accession 0001581280-25-000025.Report this figure69.6Current liabilities, Q1 FY2025, at 2024-12-31$69.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-02-03, accession 0001628280-25-003461.Report this figure75.0Current liabilities, Q2 FY2025, at 2025-03-31$75.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-05, accession 0001628280-25-022154.Report this figure87.1Current liabilities, Q3 FY2025, at 2025-06-30$87.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-04, accession 0001581280-25-000009.Report this figure91.4Current liabilities, FY2025, at 2025-09-30$91.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-03, accession 0001581280-26-000047.Report this figure80.4Current liabilities, Q1 FY2026, at 2025-12-31$80.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q/A filed 2026-02-26, accession 0001581280-26-000029.Report this figure120Current liabilities, Q2 FY2026, at 2026-03-31$120.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-04, accession 0001581280-26-000040.Report this figure120Current liabilities, Q3 FY2026, at 2026-06-30$120.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-03, accession 0001581280-26-000047.Report this figure
Total liabilities$m153Total liabilities, FY2023, at 2023-09-30$153.0m. XBRL concept us-gaap:Liabilities. 10-K filed 2024-11-18, accession 0001628280-24-048262.Report this figure143Total liabilities, Q1 FY2024, at 2023-12-31$142.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-02-02, accession 0001628280-24-003051.Report this figure143Total liabilities, Q2 FY2024, at 2024-03-31$142.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-02, accession 0001628280-24-020014.Report this figure147Total liabilities, Q3 FY2024, at 2024-06-30$147.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-02, accession 0001628280-24-034434.Report this figure142Total liabilities, FY2024, at 2024-09-30$141.6m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-11-17, accession 0001581280-25-000025.Report this figure153Total liabilities, Q1 FY2025, at 2024-12-31$152.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-02-03, accession 0001628280-25-003461.Report this figure156Total liabilities, Q2 FY2025, at 2025-03-31$155.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-05, accession 0001628280-25-022154.Report this figure165Total liabilities, Q3 FY2025, at 2025-06-30$165.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-04, accession 0001581280-25-000009.Report this figure169Total liabilities, FY2025, at 2025-09-30$168.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-03, accession 0001581280-26-000047.Report this figure182Total liabilities, Q1 FY2026, at 2025-12-31$182.0m. XBRL concept us-gaap:Liabilities. 10-Q/A filed 2026-02-26, accession 0001581280-26-000029.Report this figure221Total liabilities, Q2 FY2026, at 2026-03-31$221.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-04, accession 0001581280-26-000040.Report this figure227Total liabilities, Q3 FY2026, at 2026-06-30$226.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-03, accession 0001581280-26-000047.Report this figure
Long-term debt$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Current portion of debt$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Shareholders' equity$m623Shareholders' equity, FY2023, at 2023-09-30$623.4m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2025-11-17, accession 0001581280-25-000025.Report this figure590Shareholders' equity, Q1 FY2024, at 2023-12-31$590.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-05-05, accession 0001628280-25-022154.Report this figure560Shareholders' equity, Q2 FY2024, at 2024-03-31$560.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-08-04, accession 0001581280-25-000009.Report this figure491Shareholders' equity, Q3 FY2024, at 2024-06-30$491.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-08-04, accession 0001581280-25-000009.Report this figure473Shareholders' equity, FY2024, at 2024-09-30$472.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-03, accession 0001581280-26-000047.Report this figure456Shareholders' equity, Q1 FY2025, at 2024-12-31$455.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-05-04, accession 0001581280-26-000040.Report this figure440Shareholders' equity, Q2 FY2025, at 2025-03-31$440.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-03, accession 0001581280-26-000047.Report this figure478Shareholders' equity, Q3 FY2025, at 2025-06-30$478.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-03, accession 0001581280-26-000047.Report this figure473Shareholders' equity, FY2025, at 2025-09-30$473.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-03, accession 0001581280-26-000047.Report this figure456Shareholders' equity, Q1 FY2026, at 2025-12-31$456.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-05-04, accession 0001581280-26-000040.Report this figure455Shareholders' equity, Q2 FY2026, at 2026-03-31$455.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-03, accession 0001581280-26-000047.Report this figure446Shareholders' equity, Q3 FY2026, at 2026-06-30$445.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-03, accession 0001581280-26-000047.Report this figure

Cash flow

Operating cash flow$1.1m, Q3 FY2026
Capital expenditure$9.8m, Q3 FY2026
Twist Bioscience Corp, cash flow, quarterly
Line itemUnitQ4 FY20232023-09-30Q1 FY20242023-12-31Q2 FY20242024-03-31Q3 FY20242024-06-30Q4 FY20242024-09-30Q1 FY20252024-12-31Q2 FY20252025-03-31Q3 FY20252025-06-30Q4 FY20252025-09-30Q1 FY20262025-12-31Q2 FY20262026-03-31Q3 FY20262026-06-30
Operating cash flow$m(20.7)Operating cash flow, Q4 FY2023, three months to 2023-09-30−$20.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-11-17, accession 0001581280-25-000025. Derived: 12-month figure less the 9-month figure.Report this figure(23.0)Operating cash flow, Q1 FY2024, three months to 2023-12-31−$23.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-02-03, accession 0001628280-25-003461.Report this figure(19.4)Operating cash flow, Q2 FY2024, three months to 2024-03-31−$19.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-05, accession 0001628280-25-022154. Derived: 6-month figure less the 3-month figure.Report this figure(6.4)Operating cash flow, Q3 FY2024, three months to 2024-06-30−$6.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-04, accession 0001581280-25-000009. Derived: 9-month figure less the 6-month figure.Report this figure(15.3)Operating cash flow, Q4 FY2024, three months to 2024-09-30−$15.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-11-17, accession 0001581280-25-000025. Derived: 12-month figure less the 9-month figure.Report this figure(21.4)Operating cash flow, Q1 FY2025, three months to 2024-12-31−$21.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q/A filed 2026-02-26, accession 0001581280-26-000029.Report this figure(13.0)Operating cash flow, Q2 FY2025, three months to 2025-03-31−$13.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-04, accession 0001581280-26-000040. Derived: 6-month figure less the 3-month figure.Report this figure(1.4)Operating cash flow, Q3 FY2025, three months to 2025-06-30−$1.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-03, accession 0001581280-26-000047. Derived: 9-month figure less the 6-month figure.Report this figure(11.8)Operating cash flow, Q4 FY2025, three months to 2025-09-30−$11.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-11-17, accession 0001581280-25-000025. Derived: 12-month figure less the 9-month figure.Report this figure(24.8)Operating cash flow, Q1 FY2026, three months to 2025-12-31−$24.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q/A filed 2026-02-26, accession 0001581280-26-000029.Report this figure(17.6)Operating cash flow, Q2 FY2026, three months to 2026-03-31−$17.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-04, accession 0001581280-26-000040. Derived: 6-month figure less the 3-month figure.Report this figure1.1Operating cash flow, Q3 FY2026, three months to 2026-06-30$1.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-03, accession 0001581280-26-000047. Derived: 9-month figure less the 6-month figure.Report this figure
Capital expenditure$m2.4Capital expenditure, Q4 FY2023, three months to 2023-09-30$2.4m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-11-17, accession 0001581280-25-000025. Derived: 12-month figure less the 9-month figure.Report this figure1.5Capital expenditure, Q1 FY2024, three months to 2023-12-31$1.5m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-02-03, accession 0001628280-25-003461.Report this figure0.6Capital expenditure, Q2 FY2024, three months to 2024-03-31$603.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-05, accession 0001628280-25-022154. Derived: 6-month figure less the 3-month figure.Report this figure1.0Capital expenditure, Q3 FY2024, three months to 2024-06-30$965.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-04, accession 0001581280-25-000009. Derived: 9-month figure less the 6-month figure.Report this figure2.0Capital expenditure, Q4 FY2024, three months to 2024-09-30$2.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-11-17, accession 0001581280-25-000025. Derived: 12-month figure less the 9-month figure.Report this figure2.3Capital expenditure, Q1 FY2025, three months to 2024-12-31$2.3m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q/A filed 2026-02-26, accession 0001581280-26-000029.Report this figure4.1Capital expenditure, Q2 FY2025, three months to 2025-03-31$4.1m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-04, accession 0001581280-26-000040. Derived: 6-month figure less the 3-month figure.Report this figure9.2Capital expenditure, Q3 FY2025, three months to 2025-06-30$9.2m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-03, accession 0001581280-26-000047. Derived: 9-month figure less the 6-month figure.Report this figure12.4Capital expenditure, Q4 FY2025, three months to 2025-09-30$12.4m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-11-17, accession 0001581280-25-000025. Derived: 12-month figure less the 9-month figure.Report this figure10.0Capital expenditure, Q1 FY2026, three months to 2025-12-31$10.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q/A filed 2026-02-26, accession 0001581280-26-000029.Report this figure7.9Capital expenditure, Q2 FY2026, three months to 2026-03-31$7.9m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-04, accession 0001581280-26-000040. Derived: 6-month figure less the 3-month figure.Report this figure9.8Capital expenditure, Q3 FY2026, three months to 2026-06-30$9.8m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-03, accession 0001581280-26-000047. Derived: 9-month figure less the 6-month figure.Report this figure

Shares

Diluted shares (weighted)62.40m, Q3 FY2026
Twist Bioscience Corp, shares, quarterly
Line itemUnitQ1 FY20232022-12-31Q2 FY20232023-03-31Q3 FY20232023-06-30Q1 FY20242023-12-31Q2 FY20242024-03-31Q3 FY20242024-06-30Q1 FY20252024-12-31Q2 FY20252025-03-31Q3 FY20252025-06-30Q1 FY20262025-12-31Q2 FY20262026-03-31Q3 FY20262026-06-30
Diluted shares (weighted)m shares56.4Diluted shares (weighted), Q1 FY2023, three months to 2022-12-3156,444,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-02-02, accession 0001628280-24-003051.Report this figure56.8Diluted shares (weighted), Q2 FY2023, three months to 2023-03-3156,777,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-02, accession 0001628280-24-020014.Report this figure57.0Diluted shares (weighted), Q3 FY2023, three months to 2023-06-3057,041,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-02, accession 0001628280-24-034434.Report this figure57.5Diluted shares (weighted), Q1 FY2024, three months to 2023-12-3157,497,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-02-03, accession 0001628280-25-003461.Report this figure57.8Diluted shares (weighted), Q2 FY2024, three months to 2024-03-3157,779,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-05, accession 0001628280-25-022154.Report this figure58.1Diluted shares (weighted), Q3 FY2024, three months to 2024-06-3058,145,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-04, accession 0001581280-25-000009.Report this figure59.2Diluted shares (weighted), Q1 FY2025, three months to 2024-12-3159,162,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q/A filed 2026-02-26, accession 0001581280-26-000029.Report this figure59.6Diluted shares (weighted), Q2 FY2025, three months to 2025-03-3159,649,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-04, accession 0001581280-26-000040.Report this figure61.2Diluted shares (weighted), Q3 FY2025, three months to 2025-06-3061,164,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-03, accession 0001581280-26-000047.Report this figure61.1Diluted shares (weighted), Q1 FY2026, three months to 2025-12-3161,080,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q/A filed 2026-02-26, accession 0001581280-26-000029.Report this figure61.7Diluted shares (weighted), Q2 FY2026, three months to 2026-03-3161,702,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-04, accession 0001581280-26-000040.Report this figure62.4Diluted shares (weighted), Q3 FY2026, three months to 2026-06-3062,403,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-03, accession 0001581280-26-000047.Report this figure

Shares outstanding: 62.71mShares outstanding, period not labelled, at 2026-07-2962,707,424 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-03, accession 0001581280-26-000047.Report this figure at Jul 29, 2026, from the cover of the 10-Q filed Aug 3, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:43 ET. Listed shows no prices and gives no investment advice.